Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients.
Harden PN. et al, (2020), Am J Transplant
Brook M. et al, (2019), Cell and Gene Therapy Insights, 5, 1229 - 1236
Communications: Designing care bundle documentation to support the recognition and treatment of acute kidney injury: A route to quality improvement
Black A. et al, (2017), Design for Health, 170 - 189
Repeat testing is essential when estimating chronic kidney disease prevalence and associated cardiovascular risk.
Brook MO. et al, (2012), QJM, 105, 247 - 255
Single estimated glomerular filtration rate and albuminuria measurement substantially overestimates prevalence of chronic kidney disease.
Bottomley MJ. et al, (2011), Nephron Clin Pract, 117, c348 - c352
Regulatory T cells can prevent memory CD8+ T-cell-mediated rejection following polymorphonuclear cell depletion.
Jones ND. et al, (2010), Eur J Immunol, 40, 3107 - 3116
Location and time-dependent control of rejection by regulatory T cells culminates in a failure to generate memory T cells.
Carvalho-Gaspar M. et al, (2008), J Immunol, 180, 6640 - 6648
Yang J. et al, (2007), Proc Natl Acad Sci U S A, 104, 19954 - 19959
Brook MO. et al, (2006), Transplantation, 82, 1 - 9
Effector and memory CD8+ T cells can be generated in response to alloantigen independently of CD4+ T cell help.
Jones ND. et al, (2006), J Immunol, 176, 2316 - 2323